All announcements for “PHARMA”
| Date | Category | Title | Ref |
|---|---|---|---|
| 20/08/2021 | Entitlement(Notice of Book Closure) | Second Interim Dividend | ENT-20082021-00001 |
| 20/08/2021 | Change in Boardroom | Change in Boardroom | C03-20082021-00005 |
| 12/08/2021 | General Announcement for PLC | OTHERS Surat Setuju Terima for the Supply and Distribution of Covid-19 Vaccine Coronavac Suspension for Injection between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad and Government of Malaysia. | GA1-12082021-00014 |
| 16/07/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-16072021-00127 |
| 12/07/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-09072021-00017 |
| 08/07/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-08072021-00015 |
| 07/07/2021 | General Announcement for PLC | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE | GA1-05072021-00025 |
| 06/07/2021 | General Announcement for PLC | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE | GA1-06072021-00089 |
| 06/07/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-06072021-00006 |
| 01/07/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-01072021-00027 |